Concord Asset Management »

Vertex Pharmaceuticals Incorporated shares owned by Concord Asset Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Concord Asset Management from 13F filings

Historical chart of Concord Asset Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Concord Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Concord Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 2.8k 465.08
2024-06-30 $1.1M 2.3k 468.72
2024-03-31 $649k 1.6k 418.01
2023-12-31 $466k 1.1k 406.89
2023-09-30 $230k 661 347.74

More positions owned by Concord Asset Management

Spdr Ser Tr Portfolio Short (SPSB)
Vaneck Etf Trust Ig Floating Rate (FLTR)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Ishares Tr Short Treas Bd (SHV)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Apple (AAPL)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Microsoft Corporation (MSFT)
Ishares Tr Core Div Grwth (DGRO)
NVIDIA Corporation (NVDA)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Meta Platforms Cl A (META)

View all positions for Concord Asset Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Amundi
Morgan Stanley
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated